EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study

<b>Background</b>: A 2016 meta-analysis of pharmaceutical care for patients with diabetes mellitus showed that the following four components were most effective: (a) individual goal setting, (b) sending feedback to the physician, (c) reviewing the medication, and (d) reviewing blood gluc...

Full description

Bibliographic Details
Main Authors: Maira Anna Deters, Emina Obarcanin, Holger Schwender, Stephanie Läer
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Pharmacy
Subjects:
Online Access:https://www.mdpi.com/2226-4787/9/3/137
id doaj-d6046b5574814f328514b8baf6a7d44a
record_format Article
spelling doaj-d6046b5574814f328514b8baf6a7d44a2021-09-26T00:57:32ZengMDPI AGPharmacy2226-47872021-08-01913713710.3390/pharmacy9030137EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept StudyMaira Anna Deters0Emina Obarcanin1Holger Schwender2Stephanie Läer3Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University, 40225 Duesseldorf, GermanyInstitute of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University, 40225 Duesseldorf, GermanyMathematical Institute, Heinrich Heine University, 40225 Duesseldorf, GermanyInstitute of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University, 40225 Duesseldorf, Germany<b>Background</b>: A 2016 meta-analysis of pharmaceutical care for patients with diabetes mellitus showed that the following four components were most effective: (a) individual goal setting, (b) sending feedback to the physician, (c) reviewing the medication, and (d) reviewing blood glucose measurements. <b>Methods:</b> To formulate a hypothesis regarding the effect of these four pharmaceutical care components on glycemic control in patients with diabetes mellitus and the feasibility of these components in practice. Ten patients with type 2 diabetes were included in the case series and received medication therapy management over four months. <b>Results:</b> The four care components were feasible in everyday practice and could be implemented within one patient visit. The average visits were 49 and 28 min at the beginning and end of the study, respectively. The glycated hemoglobin values did not change over the study period, though the fasting blood glucose decreased from 142 to 120 mg/dl, and the number of unsolved drug-related problems decreased from 6.9 to 1.9 per patient by the study end. <b>Conclusions:</b> This case series supports the hypothesis that community pharmacists can implement structured pharmaceutical care in everyday pharmacy practice for patients with type 2 diabetes mellitus.https://www.mdpi.com/2226-4787/9/3/137diabetespharmaceutical carecommunity practice
collection DOAJ
language English
format Article
sources DOAJ
author Maira Anna Deters
Emina Obarcanin
Holger Schwender
Stephanie Läer
spellingShingle Maira Anna Deters
Emina Obarcanin
Holger Schwender
Stephanie Läer
EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study
Pharmacy
diabetes
pharmaceutical care
community practice
author_facet Maira Anna Deters
Emina Obarcanin
Holger Schwender
Stephanie Läer
author_sort Maira Anna Deters
title EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study
title_short EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study
title_full EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study
title_fullStr EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study
title_full_unstemmed EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study
title_sort emdia case series—effective medication therapy management (mtm) for diabetes type 2 patients—a proof of concept study
publisher MDPI AG
series Pharmacy
issn 2226-4787
publishDate 2021-08-01
description <b>Background</b>: A 2016 meta-analysis of pharmaceutical care for patients with diabetes mellitus showed that the following four components were most effective: (a) individual goal setting, (b) sending feedback to the physician, (c) reviewing the medication, and (d) reviewing blood glucose measurements. <b>Methods:</b> To formulate a hypothesis regarding the effect of these four pharmaceutical care components on glycemic control in patients with diabetes mellitus and the feasibility of these components in practice. Ten patients with type 2 diabetes were included in the case series and received medication therapy management over four months. <b>Results:</b> The four care components were feasible in everyday practice and could be implemented within one patient visit. The average visits were 49 and 28 min at the beginning and end of the study, respectively. The glycated hemoglobin values did not change over the study period, though the fasting blood glucose decreased from 142 to 120 mg/dl, and the number of unsolved drug-related problems decreased from 6.9 to 1.9 per patient by the study end. <b>Conclusions:</b> This case series supports the hypothesis that community pharmacists can implement structured pharmaceutical care in everyday pharmacy practice for patients with type 2 diabetes mellitus.
topic diabetes
pharmaceutical care
community practice
url https://www.mdpi.com/2226-4787/9/3/137
work_keys_str_mv AT mairaannadeters emdiacaseserieseffectivemedicationtherapymanagementmtmfordiabetestype2patientsaproofofconceptstudy
AT eminaobarcanin emdiacaseserieseffectivemedicationtherapymanagementmtmfordiabetestype2patientsaproofofconceptstudy
AT holgerschwender emdiacaseserieseffectivemedicationtherapymanagementmtmfordiabetestype2patientsaproofofconceptstudy
AT stephanielaer emdiacaseserieseffectivemedicationtherapymanagementmtmfordiabetestype2patientsaproofofconceptstudy
_version_ 1716869506990604288